ArticleEuropean journal of medical research2025

Therapeutic efficacy of 5-alkylresorcinol on progression of colorectal cancer by activating HCLS1 and suppressing TLR4/MYD88/NF-κB signaling.

Chun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.